Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women

Harriet Johansson, Sara Gandini, Bernardo Bonanni, Frederique Mariette, Aliana Guerrieri-Gonzaga, Davide Serrano, Enrico Cassano, Francesca Ramazzotto, Laura Baglietto, Maria Teresa Sandri, Andrea Decensi

Research output: Contribution to journalArticle

Abstract

Background: Endogenous hormones and insulin-like growth factors (IGF) play a central role in breast cancer development. Mammographic density, an important breast cancer risk factor, has been associated with these biomarkers in premenopausal women. The aim of this study was to assess the relationships between circulating hormones, clinical features related to breast cancer risk and mammographic density in postmenopausal women. Subjects and methods: The study included 226 postmenopausal women participating in a clinical prevention trial. We performed baseline measurements of mammographic percent density and circulating levels of estradiol, sex-hormone binding globulin (SHBG), follicle stimulating hormone (FSH), prolactin, C-terminal cross-link telopeptide, IGF-I, and IGF binding protein-3. Results: Median age and time since last menses were 52 years and 15 months, respectively. Median body mass index was 24.1 kg/m 2. After adjusting for age and body mass index, estradiol was the only biomarker significantly correlated with mammographic density (r = 0.17; P = 0.04). Women with normal body mass index had higher mammographic density (P <0.001), higher SHBG (P <0.0001), higher FSH (P = 0.002) and lower estradiol levels (P = 0.01) than those who were overweight. Women who had previous biopsies for benign breast disease had a higher mammographic density (P = 0.006). Conclusions: In these recently postmenopausal women, mammographic percent density is directly associated with circulating estradiol levels. Our results provide further support to the role of circulating hormones in breast cancer risk.

Original languageEnglish
Pages (from-to)57-67
Number of pages11
JournalBreast Cancer Research and Treatment
Volume108
Issue number1
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Hormones
Breast Neoplasms
Estradiol
Sex Hormone-Binding Globulin
Body Mass Index
Follicle Stimulating Hormone
Biomarkers
Insulin-Like Growth Factor Binding Protein 3
Breast Diseases
Menstruation
Somatomedins
Breast Density
Insulin-Like Growth Factor I
Prolactin
Clinical Trials
Biopsy

Keywords

  • Biomarkers
  • Breast cancer risk
  • C-terminal cross-link telopeptide
  • Insulin-like growth factor I
  • Mammographic density
  • Prolactin
  • Sex steroid hormones

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{a731154e6c914f37b83ce35813ed259f,
title = "Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women",
abstract = "Background: Endogenous hormones and insulin-like growth factors (IGF) play a central role in breast cancer development. Mammographic density, an important breast cancer risk factor, has been associated with these biomarkers in premenopausal women. The aim of this study was to assess the relationships between circulating hormones, clinical features related to breast cancer risk and mammographic density in postmenopausal women. Subjects and methods: The study included 226 postmenopausal women participating in a clinical prevention trial. We performed baseline measurements of mammographic percent density and circulating levels of estradiol, sex-hormone binding globulin (SHBG), follicle stimulating hormone (FSH), prolactin, C-terminal cross-link telopeptide, IGF-I, and IGF binding protein-3. Results: Median age and time since last menses were 52 years and 15 months, respectively. Median body mass index was 24.1 kg/m 2. After adjusting for age and body mass index, estradiol was the only biomarker significantly correlated with mammographic density (r = 0.17; P = 0.04). Women with normal body mass index had higher mammographic density (P <0.001), higher SHBG (P <0.0001), higher FSH (P = 0.002) and lower estradiol levels (P = 0.01) than those who were overweight. Women who had previous biopsies for benign breast disease had a higher mammographic density (P = 0.006). Conclusions: In these recently postmenopausal women, mammographic percent density is directly associated with circulating estradiol levels. Our results provide further support to the role of circulating hormones in breast cancer risk.",
keywords = "Biomarkers, Breast cancer risk, C-terminal cross-link telopeptide, Insulin-like growth factor I, Mammographic density, Prolactin, Sex steroid hormones",
author = "Harriet Johansson and Sara Gandini and Bernardo Bonanni and Frederique Mariette and Aliana Guerrieri-Gonzaga and Davide Serrano and Enrico Cassano and Francesca Ramazzotto and Laura Baglietto and Sandri, {Maria Teresa} and Andrea Decensi",
year = "2008",
month = "3",
doi = "10.1007/s10549-007-9577-9",
language = "English",
volume = "108",
pages = "57--67",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York LLC",
number = "1",

}

TY - JOUR

T1 - Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women

AU - Johansson, Harriet

AU - Gandini, Sara

AU - Bonanni, Bernardo

AU - Mariette, Frederique

AU - Guerrieri-Gonzaga, Aliana

AU - Serrano, Davide

AU - Cassano, Enrico

AU - Ramazzotto, Francesca

AU - Baglietto, Laura

AU - Sandri, Maria Teresa

AU - Decensi, Andrea

PY - 2008/3

Y1 - 2008/3

N2 - Background: Endogenous hormones and insulin-like growth factors (IGF) play a central role in breast cancer development. Mammographic density, an important breast cancer risk factor, has been associated with these biomarkers in premenopausal women. The aim of this study was to assess the relationships between circulating hormones, clinical features related to breast cancer risk and mammographic density in postmenopausal women. Subjects and methods: The study included 226 postmenopausal women participating in a clinical prevention trial. We performed baseline measurements of mammographic percent density and circulating levels of estradiol, sex-hormone binding globulin (SHBG), follicle stimulating hormone (FSH), prolactin, C-terminal cross-link telopeptide, IGF-I, and IGF binding protein-3. Results: Median age and time since last menses were 52 years and 15 months, respectively. Median body mass index was 24.1 kg/m 2. After adjusting for age and body mass index, estradiol was the only biomarker significantly correlated with mammographic density (r = 0.17; P = 0.04). Women with normal body mass index had higher mammographic density (P <0.001), higher SHBG (P <0.0001), higher FSH (P = 0.002) and lower estradiol levels (P = 0.01) than those who were overweight. Women who had previous biopsies for benign breast disease had a higher mammographic density (P = 0.006). Conclusions: In these recently postmenopausal women, mammographic percent density is directly associated with circulating estradiol levels. Our results provide further support to the role of circulating hormones in breast cancer risk.

AB - Background: Endogenous hormones and insulin-like growth factors (IGF) play a central role in breast cancer development. Mammographic density, an important breast cancer risk factor, has been associated with these biomarkers in premenopausal women. The aim of this study was to assess the relationships between circulating hormones, clinical features related to breast cancer risk and mammographic density in postmenopausal women. Subjects and methods: The study included 226 postmenopausal women participating in a clinical prevention trial. We performed baseline measurements of mammographic percent density and circulating levels of estradiol, sex-hormone binding globulin (SHBG), follicle stimulating hormone (FSH), prolactin, C-terminal cross-link telopeptide, IGF-I, and IGF binding protein-3. Results: Median age and time since last menses were 52 years and 15 months, respectively. Median body mass index was 24.1 kg/m 2. After adjusting for age and body mass index, estradiol was the only biomarker significantly correlated with mammographic density (r = 0.17; P = 0.04). Women with normal body mass index had higher mammographic density (P <0.001), higher SHBG (P <0.0001), higher FSH (P = 0.002) and lower estradiol levels (P = 0.01) than those who were overweight. Women who had previous biopsies for benign breast disease had a higher mammographic density (P = 0.006). Conclusions: In these recently postmenopausal women, mammographic percent density is directly associated with circulating estradiol levels. Our results provide further support to the role of circulating hormones in breast cancer risk.

KW - Biomarkers

KW - Breast cancer risk

KW - C-terminal cross-link telopeptide

KW - Insulin-like growth factor I

KW - Mammographic density

KW - Prolactin

KW - Sex steroid hormones

UR - http://www.scopus.com/inward/record.url?scp=40249120009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40249120009&partnerID=8YFLogxK

U2 - 10.1007/s10549-007-9577-9

DO - 10.1007/s10549-007-9577-9

M3 - Article

C2 - 17468953

AN - SCOPUS:40249120009

VL - 108

SP - 57

EP - 67

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -